Bank of India Share Price in Focus; Board Approves ₹7,500 Crore Basel-III Bond Fundraise

Bank of India’s board has cleared a proposal to raise up to ₹7,500 crore through Basel-III compliant bonds.  

The decision was taken at a board meeting held on 30 April 2026, as per an exchange filing submitted by the bank. 

Mix of Tier-I and Tier-II Bonds 

The planned fundraise will include ₹2,500 crore through Additional Tier-I (AT1) bonds and ₹5,000 crore via Tier-II bonds.  

These instruments form part of regulatory capital and are issued by banks to meet capital adequacy requirements set under Basel-III norms. 

Planned During FY27 

The bank has indicated that the issuance will take place during the financial year 2026-27. The fundraising may be done in tranches, allowing the lender to access the market at different points depending on its funding needs and prevailing conditions. 

Board Meeting and Disclosure 

According to the filing, the board meeting started at 3:30 PM and ended at 5:50 PM on the same day.  

The approval follows an earlier intimation dated 27 April 2026. The update has been shared with both stock exchanges for public disclosure.  

Role of These Bonds 

AT1 bonds are perpetual instruments and are used to strengthen a bank’s core capital. Tier-II bonds have a fixed tenure and are counted as supplementary capital.  

Together, they help banks maintain required capital ratios as lending activity grows. 

Read More: Tata Electronics Workforce Reaches 75,000; Becomes Apple’s Largest Manufacturer in India! 

Bank of India Share Price Performance  

As of April 30, 2026, at 3:30 pm, Bank of India share price closed at ₹139.94, down 2.28% from the previous closing price. 

Conclusion 

The approved plan gives Bank of India an option to raise funds through debt instruments in FY27. The structure indicates a split between core and supplementary capital, in line with regulatory requirements. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.   
 
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.